Stay updated on Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The revision line in the page footer updated from v3.6.4 to v3.6.5, signaling a minor maintenance update.
    Difference
    0.1%
    Check dated 2026-08-08T16:55:14.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4, signaling a version upgrade of the page. The content and study details appear unchanged.
    Difference
    0.1%
    Check dated 2026-07-25T08:22:17.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.6.2 to v3.6.3, reflecting a new build of the page.
    Difference
    0.1%
    Check dated 2026-07-03T21:45:50.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.2, indicating a newer build of the page. No study content or functionality were altered.
    Difference
    0.1%
    Check dated 2026-06-26T20:26:59.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page now indicates that the study is completed and no longer looking for participants. Enrollment has closed and no new participants are being sought.
    Difference
    0.5%
    Check dated 2026-06-12T13:23:16.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, indicating a new version of the page or its template. This is a metadata update and does not reflect substantive changes to the study data or content.
    Difference
    0.1%
    Check dated 2026-06-05T10:08:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial page.